(Q72855271)
Statements
Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia (English)
Insull W Jr
Black D
Dujovne C
Hosking JD
Hunninghake D
Keilson L
Knopp R
McKenney J
Stein E
1 November 1994